|
2026
|
Invention
|
Modified uricase and uses thereof.
A modified uricase is described herein, as well as a method o... |
|
|
Invention
|
Compositions and methods for treating diseases associated with ricin intoxication. The invention ... |
|
2025
|
Invention
|
Stabilized alpha-galactosidase and uses thereof.
Multimeric protein structures comprising at lea... |
|
|
Invention
|
Methods of treating diseases associated with elevated uric acid.
A method of treating a disease ... |
|
|
Invention
|
Therapeutic regimen for the treatment of fabry using stabilized alpha-galactosidase.
Methods of ... |
|
2024
|
Invention
|
Methods of treating diseases associated with elevated uric acid. A method of treating a disease o... |
|
2022
|
Invention
|
Stabilized alpha-galactosidase and uses thereof. Multimeric protein structures comprising at leas... |
|
2021
|
Invention
|
Modified dnase and uses thereof. Modified DNase I protein in which one or more amino acids of a D... |
|
|
Invention
|
Modified uricase and uses thereof. A modified uricase is described herein, as well as a method of... |
|
|
Invention
|
Long-acting dnase.
A modified DNase protein is described herein as well as pharmaceutical compos... |
|
|
Invention
|
Long-acting dnase. A modified DNase protein is described herein as well as pharmaceutical composi... |
|
|
Invention
|
Dicer-like knock-out plant cells.
DICER-liker knock-out plant cells are provided. Accordingly, t... |
|
|
Invention
|
Dicer-like knock-out plant cells. DICER-liker knock-out plant cells are provided. Accordingly, th... |
|
2019
|
Invention
|
Removal of constructs from transformed cells. A nucleic acid construct is disclosed which is remo... |
|
2018
|
Invention
|
Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of produc... |
|
|
Invention
|
Therapeutic regimen for the treatment of fabry using stabilized alpha-galactosidase. Methods of t... |
|
2017
|
Invention
|
Stabilized α-galactosidase and uses thereof. Multimeric protein structures comprising at least tw... |
|
2015
|
Invention
|
Plant cell culture expressing human lysosomal proteins and uses thereof.
A device, system and me... |
|
|
Invention
|
Method of maintaining disease stability in a subject having gaucher's disease.
A method of maint... |
|
|
Invention
|
Method of maintaining disease stability in a subject having gaucher's disease. A method of mainta... |
|
2014
|
Invention
|
Plant cell culture expressing human lysosomal proteins and uses thereof. A device, system and met... |
|
|
Invention
|
Saccharide-containing protein conjugates and uses thereof.
Conjugates of a saccharide and a biom... |
|
|
Invention
|
Tnf alpha inhibitor polypeptides, polynucleotides encoding same, cells expressing same and method... |
|
|
Invention
|
Use of plant cells expressing a tnfalpha polypeptide inhibitor in therapy. A method of treating a... |
|
2013
|
Invention
|
Oral unit dosage forms and uses of same for the treatment of gaucher disease.
A method of treati... |
|
|
Invention
|
Oral unit dosage forms and uses of same for the treatment of gaucher disease. A method of treatin... |
|
|
Invention
|
Dry powder formulations of dnase i. DNase I formulations for pulmonary administration and, more p... |
|
|
Invention
|
Inhalable liquid formulations of dnase i. An inhalable pharmaceutical composition for pulmonary a... |
|
|
Invention
|
Dnase i polypeptides, polynucleotides encoding same, methods of producing dnase i and uses thereo... |
|
2011
|
Invention
|
Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells. Nucleic a... |
|
2008
|
G/S
|
Chemical, biochemical, biological and biotechnological preparations and substances for producing ... |
|
2007
|
G/S
|
[ Chemical, biochemical, biological and biotechnological preparations and substances for scientif... |
